We begin with a story about Kobi. Kobi was in an accident a number of years ago and was left limping and in constant pain. He exhausted his options in traditional treatments to find reprieve from a state that was impeding his life in many ways. When Kobi’s doctor talked to him about stem cell treatment, he said he would have to spend thousands of dollars and travel to another country to get the treatment. Feeling hopeful that stem cells might actually make the difference for him, he enrolled in a study to receive stem cell treatments. As Kobi tells it, he’s “feeling so much better these days and is getting better by the minute.” Kobi also happens to be the Operations Engineer of SCI and knows first hand just how important the work that SCI is doing really is.

Next, we consider a story that started over ten years ago and has since become one of the most talked about stem cell treatment stories around the world. Doctors were careful to not get patients hopes up who were suffering from ALS (Amyotrophic Lateral Sclerosis), it turns out that what doctors found even more astonishing than the way treatments were working, was the patient’s ambition to undergo treatment. It turns out that how patients approach treatment has an impact on their ability to see results. After first testing stem cell transplants in laboratory rats, doctors got FDA approval to run an 18-person test. While no promises were being made, hopes were high, and patients have begun to undergo treatment. From SCI’s perspective, the acceptance and adoption of stem cell treatments as legitimate and opportunity-rich is music to their ears. They work the company does promote the research and development of such treatments and will bring such treatments to patients near and far.

SCI focuses a lot on the health and wellness of families and communities at large, but there are many other applications of stem cell treatment, research, and development that SCI can have a hand in promoting and brokering. Take sports, for example. Recent breakthroughs related to aging muscle cells have been shown to have a “point of no return.” Besides sounding dramatic, it basically means that if we can treat aging muscle before it loses too much of its original cellular structure, it can be restored, or at least, it can be slowed down. Rather than trying to fight the aging process, markers can be potentially identified to tell us when to intervene and when it is too late. While this might sound like the fountain of youth, you can rest assured, it is not. It is, however, incredibly good news for aging athletes, or other professionals who rely on their physical aptitude to earn a living.

Finally, we go to one of the areas of stem cell treatments that are making real waves in the medical community: treating blindness. Still in its early stages, these stem cell treatments are providing real hope for people who suffer from certain kinds of blindness; in particular, age-related macular degeneration. Studies are focusing on two individuals who received treatments for age-related macular degeneration and were able to regain enough of their original sight to be able to read again. This treatment is not an injection or therapy, it is a process by which stem cell specialists have grown carbon copies of the retinas that are impacted by the macular degeneration, and they are being transplanted in suitable cases.

It’s remarkable to think about all that stem cells can do and offer the human race. SCI not only sees this potential, the company along with its vast network of professional supporters, is

working to bring that potential to the general public. Providing a real opportunity for families and patients to get access to these potentially life-changing and improving treatments is at the heart of everything SCI does and when the SCIApplication launches in 2019, the company will begin to break down the barriers that exist for people who would benefit from these and other treatments.

For more information about how SCI is helping to break down stem cell treatment barriers, visit us at www.scia.io